IRWD icon

Ironwood Pharmaceuticals

220 hedge funds and large institutions have $672M invested in Ironwood Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 69 increasing their positions, 76 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

5.78% less ownership

Funds ownership: 107.87%102.09% (-5.8%)

15% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 46

40% less capital invested

Capital invested by funds: $1.12B → $672M (-$445M)

Holders
220
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$46.4M
Puts
$50K
Net Calls
Net Calls Change

Top Sellers

1 -$16.8M
2 -$9.1M
3 -$8.61M
4
First Eagle Investment Management
First Eagle Investment Management
New York
-$7.2M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$6.37M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$3.67M
27
$3.24M
28
$3.03M
29
$2.87M
30
$2.73M
31
$2.46M
32
$2.4M
33
$2.36M
34
$2.35M
35
$2.32M
36
$2.17M
37
$2.15M
38
$1.91M
39
$1.88M
40
$1.88M
41
$1.73M
42
$1.72M
43
$1.69M
44
$1.68M
45
$1.67M
46
$1.63M
47
$1.57M
48
$1.45M
49
$1.43M
50
$1.39M